Epigenome-wide Association Study of Breast Cancer Using Prospectively Collected Sister Study Samples
Open Access
- 10 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 105 (10) , 694-700
Abstract
Previous studies have suggested DNA methylation in blood is a potential epigenetic marker of cancer risk, but this has not been evaluated on a genome-wide scale in prospective studies for breast cancer. We measured DNA methylation at 27578 CpGs in blood samples from 298 women who developed breast cancer 0 to 5 years after enrollment in the Sister Study cohort and compared them with a random sample of 612 cohort women who remained cancer free. We also genotyped women for nine common polymorphisms associated with breast cancer. We identified 250 differentially methylated CpGs (dmCpGs) between case subjects and noncase subjects (false discovery rate [FDR] Q < 0.05). Of these dmCpGs, 75.2% were undermethylated in case subjects relative to noncase subjects. Women diagnosed within 1 year of blood draw had small but consistently greater divergence from noncase subjects than did women diagnosed at more than 1 year. Gene set enrichment analysis identified Kyoto Encyclopedia of Genes and Genomes cancer pathways at the recommended FDR of Q less than 0.25. Receiver operating characteristic analysis estimated a prediction accuracy of 65.8% (95% confidence interval = 61.0% to 70.5%) for methylation, compared with 56.0% for the Gail model and 58.8% for genome-wide association study polymorphisms. The prediction accuracy of just five dmCpGs (64.1%) was almost as good as the larger panel and was similar (63.1%) when replicated in a small sample of 81 women with diverse ethnic backgrounds. Methylation profiling of blood holds promise for breast cancer detection and risk prediction.Keywords
This publication has 31 references indexed in Scilit:
- DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population‐based studyThe FASEB Journal, 2012
- Interactions Between Genetic Variants and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort ConsortiumJNCI: Journal of the National Cancer Institute, 2011
- Epigenome-wide association studies for common human diseasesNature Reviews Genetics, 2011
- Performance of Common Genetic Variants in Breast-Cancer Risk ModelsNew England Journal of Medicine, 2010
- Association between global DNA hypomethylation in leukocytes and risk of breast cancerCarcinogenesis, 2009
- Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patientsHuman Molecular Genetics, 2009
- The Epigenomics of CancerCell, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003